Intermedine
Intermedine is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target calcitonin receptor and calcitonin gene-related peptide type 1 receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
204 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Adrenal insufficiency | D000309 | — | — | 2 | — | 1 | 2 | 7 | 12 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 2 | 3 | 5 | 2 | 12 |
| Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | 2 | 2 | 3 | 3 | 8 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | 4 | 2 | 7 |
| Proteinuria | D011507 | — | R80 | — | 1 | 1 | 2 | 3 | 7 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 3 | 1 | 1 | 2 | 7 |
| Sclerosis | D012598 | — | — | — | 1 | 2 | 2 | 2 | 6 |
| Pelvic organ prolapse | D056887 | EFO_0004710 | — | — | — | — | 1 | 5 | 6 |
| Healthy volunteers/patients | — | — | — | 1 | — | — | 2 | 2 | 5 |
| Nephrotic syndrome | D009404 | EFO_0004255 | N04 | — | 1 | 2 | 2 | — | 5 |
Show 35 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | 4 | 5 | — | 3 | 12 |
| Cushing syndrome | D003480 | EFO_0003099 | E24 | — | 2 | 4 | — | 4 | 10 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | 2 | — | 2 | 6 |
| Ectopic acth syndrome | D000182 | EFO_1001256 | E24.3 | — | 1 | 4 | — | 1 | 6 |
| Pituitary diseases | D010900 | — | E23.7 | — | 1 | 2 | — | 2 | 5 |
| Syndrome | D013577 | — | — | — | — | 2 | — | 3 | 5 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 3 | — | 1 | 4 |
| Neoplasms | D009369 | — | C80 | — | — | 1 | — | 2 | 3 |
| Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | 2 | — | 1 | 3 |
| Adrenal cortex neoplasms | D000306 | — | C74.0 | — | — | 2 | — | 1 | 3 |
Show 32 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | — | — | 1 | 3 |
| Headache | D006261 | — | R51 | — | 2 | — | — | — | 2 |
| Duchenne muscular dystrophy | D020388 | EFO_0000429 | — | — | 1 | — | — | 1 | 2 |
| Dermatomyositis | D003882 | EFO_0000398 | M33 | — | 1 | — | — | 1 | 2 |
| Polymyositis | D017285 | EFO_0003063 | M33.2 | — | 1 | — | — | 1 | 2 |
| Congenital adrenal hyperplasia | D000312 | — | E25.0 | — | 2 | — | — | — | 2 |
| Adrenocortical hyperfunction | D000308 | EFO_1000797 | — | — | 1 | — | — | — | 1 |
| Acth-secreting pituitary adenoma | D049913 | — | — | — | 1 | — | — | — | 1 |
| Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | — | 1 |
| Microsatellite instability | D053842 | — | — | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 2 | — | — | — | 2 | 4 |
| Hyperandrogenism | D017588 | — | — | 1 | — | — | — | 1 | 2 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
| Diabetic ketoacidosis | D016883 | EFO_1000897 | — | 1 | — | — | — | — | 1 |
| Newborn infant diseases | D007232 | — | — | 1 | — | — | — | — | 1 |
| Adrenal cortex diseases | D000303 | — | — | 1 | — | — | — | — | 1 |
| Marijuana abuse | D002189 | EFO_0007191 | F12 | 1 | — | — | — | — | 1 |
| Cannabis | D002188 | — | — | 1 | — | — | — | — | 1 |
| Smoking | D012907 | EFO_0004318 | — | 1 | — | — | — | — | 1 |
| Metabolic bone diseases | D001851 | — | — | 1 | — | — | — | — | 1 |
Show 5 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | — | 3 | 3 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 3 | 3 |
| Obstructive lung diseases | D008173 | — | — | — | — | — | — | 3 | 3 |
| Uterine prolapse | D014596 | EFO_1001864 | N81.4 | — | — | — | — | 3 | 3 |
| Ventral hernia | D006555 | EFO_1001866 | K43 | — | — | — | — | 3 | 3 |
| Back pain | D001416 | — | M54 | — | — | — | — | 2 | 2 |
| Gout | D006073 | EFO_0004274 | M10 | — | — | — | — | 2 | 2 |
| Brain injuries | D001930 | — | S06.9 | — | — | — | — | 2 | 2 |
| Menopause | D008593 | EFO_0003922 | N95 | — | — | — | — | 2 | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 2 | 2 |
Show 77 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Intermedine |
| INN | intermedine |
| Description | INTERMEDINE |
| Classification | Protein |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C |
Identifiers
| PDB | — |
| CAS-ID | 581-05-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL214332 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | OVF025LA77 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
CALCRL
CALCRL
Organism
Homo sapiens
Gene name
CALCRL
Gene synonyms
CGRPR
NCBI Gene ID
Protein name
calcitonin gene-related peptide type 1 receptor
Protein synonyms
calcitonin receptor-like, Calcitonin receptor-like receptor, CGRP type 1 receptor
Uniprot ID
Mouse ortholog
Calcrl (54598)
calcitonin gene-related peptide type 1 receptor (Q9WUP2)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 22,952 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
10 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use